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Rotaviruses are recognized as the leading cause of severe dehydrating diarrhea in infants and young children
worldwide. Preventive and therapeutic strategies are urgently needed to fight this pathogen. In tissue culture
and in vivo, rotavirus induces structural and functional alterations in the host cell. In order to better
understand the molecular mechanisms involved in the events after rotavirus infection, we identified host
cellular genes whose mRNA levels changed after infection. For this analysis, we used microarrays containing
more than 38,000 human cDNAs to study the transcriptional response of the human intestinal cell line Caco-2
to rotavirus infection. We found that 508 genes were differentially regulated >2-fold at 16 h after rotavirus
infection, and only one gene was similarly regulated at 1 h postinfection. Of these transcriptional changes, 73%
corresponded to the upregulation of genes, with the majority of them occurring late, at 12 or more hours
postinfection. Some of the regulated genes were classified according to known biological function and included
genes encoding integral membrane proteins, interferon-regulated genes, transcriptional and translational
regulators, and calcium metabolism-related genes. A new picture of global transcriptional regulation in the
infected cell is presented and families of genes which may be involved in viral pathogenesis are discussed.
Rotaviruses are the leading cause of severe dehydrating di-
arrhea in infants and young children worldwide (22, 30). Given
the importance of this pathogen to human health, preventive
and therapeutic strategies are urgently required. Studies di-
rected at better understanding the host cellular events follow-
ing rotavirus infection are likely to provide insights which will
advance progress toward preventing and/or treating this infec-
tion.
Rotaviruses, members of the Reoviridae family, are nonen-
veloped viruses composed of 11 segments of double-stranded
RNA (dsRNA) surrounded by three concentric layers of pro-
tein (15). In vivo, the virus infects the mature, differentiated
enterocyte of the small intestinal epithelium (4). The majority
of our knowledge about the virus replication cycle comes from
studies performed in tissue culture cells, to which rotaviruses
have been adapted to grow. These studies showed that the
entire viral replication cycle occurs in the cytoplasm of the
infected cell (reviewed in reference 15). However, little is
known about the molecular mechanisms underlying the cellu-
lar response to infection. Viruses cause a variety of responses
in infected cells, including changes in gene and protein expres-
sion, interferon (IFN) response, regulation of cell surface mol-
ecules, etc. A reduction in cellular protein synthesis has been
reported in rotavirus-infected cells (25). Changes in intracel-
lular Ca2 concentration (associated with virus maturation and
proposed to be related to cell death) (41), alterations in the
organization of the cell cytoskeleton (5, 28), structural and
functional alterations in the tight junctions (43), and cellular
lysis (15) have also been described following rotavirus infec-
tion. These phenotypic responses could be associated with
alterations in mRNA expression of particular host cell genes.
In addition, identification of changes in expression levels of
other genes in rotavirus-infected cells can provide insights con-
cerning the mechanisms of viral pathogenesis. Some limited
attempts have been made to characterize the mRNA and pro-
tein expression levels of certain cellular genes in rotavirus-
infected cells. Northern blot analysis and two-dimensional gel
electrophoresis showed that, in MA104 cells infected with the
SA11 strain of simian rotavirus, there is an increase in the
mRNA and protein levels of two endoplasmic reticulum (ER)-
resident chaperones (GRP78 and GRP94) (58). Rollo et al.
(46) showed increases in the mRNA expression level of certain
chemokines and IFNs in rhesus rotavirus (RRV)-infected
HT-29 cells. To date, no studies have been presented that
describe the global transcriptional response of cells undergoing
rotavirus infection.
The emergence in the last several years of DNA microarray
technology provides a powerful tool for studying the simulta-
neous transcriptional expression of thousands of host genes.
Oligonucleotide- and cDNA-based arrays have been used to
study the transcriptional responses of cells subjected to a va-
riety of environmental stimuli, including viral infections, such
as cytomegalovirus (60), human immunodeficiency virus (HIV)
(21), influenza virus (20), and others (7, 42). In this work we
used microarrays containing more than 38,000 human cDNAs
to characterize the transcriptional response of human intesti-
nal Caco-2 cells to RRV infection. Caco-2 cells were selected
as a good cell culture model of human intestinal cells, and
RRV was selected because it has been orally administered to
hundreds of thousands of people as a live virus vaccine.
MATERIALS AND METHODS
Cells, viruses, and infection conditions. The human intestinal epithelial cell
line Caco-2 was obtained from the American Type Culture Collection (Rockville,
Md.). Cells were grown in RPMI 1640 medium with 300 mg of L-glutamine
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(BioWhittaker, Walkersville, Md.)/liter, supplemented with 100 IU of penicillin-
streptomycin (BioWhittaker)/ml and 15% fetal bovine serum (FBS; Gibco-BRL,
Gaithersburg, Md.). Fresh medium was replaced approximately every 10 days.
The rhesus monkey epithelial cell line MA104 was grown in Medium 199 with
Earle’s balanced salt solution, 2.2 g of NaHCO3/liter, and 100 mg of L-glutamine
(BioWhittaker)/liter, supplemented with 100 IU of penicillin and streptomy-
cin/ml and 10% FBS. Cell cultures and viral infections were kept in a 5% CO2
incubator at 37°C.
Rhesus rotavirus (RRV) was propagated as follows: monolayers of MA104
cells were infected with 1 focus-forming unit (FFU) per cell of trypsin (10
g/ml)-activated RRV in the absence of FBS. Viral lysates were harvested when
substantial cytopatic effect was observed (18 to 24 hours postinfection [hpi]) by
freezing and thawing two times. The lysates were cleared by centrifugation at
3,000 rpm in a tabletop Allegra 6R Centrifuge (Beckman Coulter, Fullerton,
Calif.) at 4°C for 10 min. Virus titers were determined in monolayers of Caco-2
cells by an FFU assay as described elsewhere (37), and aliquots of this lysate were
stored at 80°C.
For microarray experiments Caco-2 cells (passages 27 to 36) were seeded in
175-cm2 tissue culture flasks (Falcon; Becton Dickinson, Franklin Lakes, N.J.).
At 17 to 26 days postseeding, the cells were washed twice with RPMI medium
and then infected at a multiplicity of infection (MOI) of 20 FFU of trypsin-
activated RRV in a final volume of 25 ml of medium without FBS. After 1 h at
37°C, the inoculum was removed, the monolayers were washed once with me-
dium, and the cells were harvested or incubated for an additional period of 15 h.
At the end of each incubation, the cells were washed twice with phosphate-
buffered saline (PBS), and 8 ml of RNAwiz (Ambion, Austin, Tex.) were added
to the flask for extraction of total RNA. As a reference, mock-infected Caco-2
cells were treated under the same conditions as infected cells except that the
“mock” inoculum was derived from a cleared lysate of uninfected MA104 cells.
The microarray experiments reported in this work were performed as follows.
The first set of comparisons consisted of two separate RRV infections (RRVa
and RRVb) and three separate mock infections (mocka, mockb, and mockc) for
each time point (1 and 16 hpi). A total of 11 different hybridization combinations
were made (Table 1). In this analysis we made three separate comparisons of
rotavirus-infected cells to mock-infected cells as described in Table 1. The sec-
ond set of comparisons were a time course experiment (Fig. 5), which consisted
of four separate RRV infections that were harvested at 1, 6, 12, and 24 hpi and
five separate mock infections that were harvested at the 1, 2, 6, 12, and 24 h time
points. A total of five different hybridizations were made (mock 2 h versus mock
2 h as a control comparison, RRV 1 h versus mock 1 h, RRV 6 h versus mock 6 h,
RRV 12 h versus mock 12 h, and RRV 24 h versus mock 24 h).
mRNA isolation, preparation of fluorescently labeled cDNA, and hybridiza-
tion. Total RNA was extracted by using RNAwiz according to the manufacturer’s
protocol. After RNA extraction, poly(A) mRNA was purified with the FastTrack
2.0 kit (Invitrogen, Carlsbad, Calif.) according to the manufacturer’s instructions
for the isolation of mRNA starting from total RNA. The concentration of
mRNA was determined by measuring the absorbance at 260 nm.
For analysis of rotavirus infection versus mock infection, fluorescently labeled
cDNA from rotavirus-infected cells was generated by reverse transcription (RT)
by using the red fluorescent dye Cy5 (Amersham Pharmacia, Piscataway, N.J.);
fluorescent cDNA from mock-infected cells was prepared by using the green
fluorescent dye Cy3 (Amersham Pharmacia). For control comparisons (mock
versus mock and RRV versus RRV), cDNA from mock- or RRV-infected cells
was generated and fluorescently labeled during a RT reaction with Cy5 or Cy3
(see Table 1). For each RT reaction, 3 g of poly(A) mRNA was mixed with 2
g of an achored oligo(dT) primer (MWG-Biotech, High Point, N.C.) in a total
volume of 15 l, heated for 10 min at 72°C, and transferred to ice. Then, the RT
mix (6 l of 5 first-strand buffer [Gibco-BRL], 3 l of 0.1 M dithiothreitol, 0.6
l of unlabeled nucleotides [25 mM concentrations each of dCTP, dGTP, and
dATP and 15 mM dTTP; Boehringer Mannheim, Indianapolis, Ind.], 3 l of
either Cy5-dUTP or Cy3-dUTP [catalog numbers PA53021 or PA53022, respec-
tively], and 2 l of Superscript II reverse transcriptase [Gibco-BRL]) was added
in a final reaction volume of 30 l. The reaction was incubated for 2 h at 42°C,
and 15 l of 0.1 N NaOH was added to degrade the RNA (10 min at 72°C). The
mix was neutralized by addition of 15 l of 0.1 N HCl; at this time the two cDNAs
(Cy5 and Cy3 labeled) were mixed, and the final volume was increased to 500 l
with TE (10 mM Tris, pH 8.0; 1 mM EDTA). The mixed cDNAs were extracted
with 500 l of buffer saturated phenol-chloroform-isoamyl alcohol (25:24:1 [vol/
vol/vol]; Gibco-BRL), and the aqueous phase was transferred to a Microcon
YM-30 (Amicon Millipore, Bedford, Mass.), centrifuged for 10 min at 10,000
rpm in a benchtop Eppendorf 5415C centrifuge, and washed with 400 l of TE.
Next, 20 g of Cot1 human DNA (Gibco-BRL), 20 g of poly(A) RNA (Sigma),
and 20 g of tRNA (Gibco-BRL) were added, and the mixture was concentrated
to 40 l. For final probe preparation, 8 l of 20 SSC (1 SSC is 0.15 M NaCl
plus 0.015 M sodium citrate) and 4 l of 3.3% sodium dodecyl sulfate (SDS)
were added, the mixture was denaturated for 2 min at 93°C, incubated for 20 min
at room temperature, and transferred to the microarray surface. The microarray
and probe were covered with a 22-by-60-mm glass coverslip and incubated
overnight at 65°C in custom-made slide chambers maintaining the humidity with
a few drops of 3 SSC. After hybridization, the arrays were transferred to a glass
slide-rack and washed with 1 SSC–0.03% SDS until the coverslips were re-
moved, and then two additional washes of 2 min each with gentle agitation were
performed in increasing stringency solutions (0.2 and 0.05 SSC). The arrays
were dried at room temperature by centrifugation for 5 min at 500 rpm in the
Allegra 6R tabletop centrifuge.
The cDNA microarrays used in this work were produced in the Microarray
Production Facility of Stanford University, and the protocols for their production
have been described elsewhere (27, 48). These arrays contain 39,552 array ele-
ments, of which 38,432 correspond to human sequence verified genes, 447 cor-
respond to nonhuman genes, and 673 correspond to unknown samples. Detailed
protocols for the array production are available online (http://cmgm.stanford.edu
/pbrown/).
Signal detection and data analysis. The fluorescent intensity for each dye was
detected by using a GenePix 4000b microarray scanner (Axon Instruments,
Foster City, Calif.). Images were analyzed by using the GenePix Pro 3.0 software
provided with the scanner. First, each spot was defined automatically by a
spot-indicator (grid). The software automatically discards (flags) a spot (i) if the
intensity is not greater than the background threshold, (ii) if the spot has an
irregular size, or (iii) if the grid designed to that spot overlaps with an adjacent
grid (see the GenePix Pro 3.0 user’s manual for more details). After the auto-
matic gridding and flagging, a visual inspection was performed to eliminate from
the analysis all spots with signals due to visually detectable array artifacts.
GenePix Pro 3.0 displays the data in tables that can be exported in any standard
spreadsheet program.
The data files generated by the software were entered into the Stanford
Microarray Database (SMD), a custom database that maintains Web-accessible
files for further analysis (52). After submission into SMD, the red signal was
normalized by applying a single multiplicative factor to all intensities measured
for the red dye Cy5. The normalization factor was computed so that the median
Cy3/Cy5 fluorescent ratio of nonflagged spots on each array was 1.0.
To reduce the effect of nonspecific fluorescence, we filtered all nonflagged
spots as follows. First, the mean background for the red and green signal in each
array was determined by calculating the average of the median background of the
corresponding color from all nonflagged spots in the array. Then, this mean
background plus three standard deviations was established as our threshold
intensity value for each color. In addition, the mean intensity of one of the colors
per spot was required to be at least two times greater than its local background.
Genes whose spot intensities did not pass these filter criteria were eliminated
from further analysis. Based on these filter criteria, between 20,093 and 24,926 of
arrayed human genes were eliminated from our analysis.
To analyze levels of up- or downregulation, we applied a hierarchical cluster-
ing algorithm implemented by the software Cluster as described by Eisen et al.
(14). This software clusters genes according to their similarity in the pattern of
gene expression and displays the data in a dendrogram that resembles a tree
TABLE 1. Hybridization scheme designed to analyze the
transcriptional response of Caco-2 cells to RRV
infection using cDNA microarrays
Hybridization Expt descriptiona cDNA sourceb cDNA sourcec
1 Control 1 Mocka 16 h Mockb 16 h
2 Control 2 Mockc 16 h Mocka 16 h
3 Control 3 RRVa 16 h RRVb 16 h
4 Infection 1 RRVa 16 h Mocka 16 h
5 Infection 2 RRVb 16 h Mockb 16 h
6 Infection 3 RRVb 16 h Mocka 16 h
7 Control 4 Mocka 1 h Mockb 1 h
8 Control 5 Mockc 1 h Mocka 1 h
9 Infection 4 RRVa 1 h Mocka 1 h
10 Infection 5 RRVb 1 h Mockb 1 h
11 Infection 6 RRVb 1 h Mocka 1 h
a As was assigned for each microarray.
b Fluorescently labeled with red dye during the RT reaction.
c Fluorescently labeled with green dye during the RT reaction.
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(TreeView). Each row represents genes, and each column represents a single
experiment or microarray. In this TreeView image the computed red/green ratios
for each spot are represented by color display, black cells represent red/green
ratios of 1.0 (unchanged genes), red cells represent ratios with increasing inten-
sities of red (upregulated genes), and green cells represent ratios with increasing
intensities of green (downregulated genes). A detailed explanation of the Cluster
and TreeView is presented by Eisen et al. (14), and this software is available
online (http://rana.stanford.edu/software).
The selection criteria for identification of genes that were up- or downregu-
lated by the rotaviral infection are described in relation to each data set in the
result section.
Measurement of cell viability and the percentage of infected cells. Caco-2 cell
viability was determined by using the LIVE/DEAD Viability/Cytotoxicity Kit for
animal cells (Molecular Probes, Eugene, Oreg.) according to the manufacturer’s
instructions for flow cytometry analysis. Briefly, confluent monolayers of Caco-2
cells in six-well plates were or were not infected at an MOI of 30 FFUs with
trypsin-activated RRV. After 16 h of infection, the cells were washed three times
with PBS and detached by incubation in 0.05% trypsin–0.53 mM EDTA (Gibco-
BRL). After trypsinization, the cells were transferred to a tube, pelleted by
centrifugation (500  g), and washed twice with PBS. As a positive control for
dead cells, half of the cells were killed by permeabilization in 70% methanol-PBS
for 20 min at room temperature. Then, cells were resuspended in 400 l of 1 M
calcein AM and 2 M ethidium homodimer (EthD-1) in PBS and incubated for
15 min at room temperature. After incubation, the fluorescent signal was ana-
lyzed by using a FACScan flow cytometer and CellQuest software (Becton
Dickinson) with appropriate gating parameters.
For quantification of the percentage of infected cells, cells were mock or RRV
infected as described above. After trypsinization, cells were fixed in 10% forma-
lin in PBS for 30 min at room temperature and then permeabilized for 3 min in
1% Triton X-100 in PBS at room temperature. The cells were washed twice with
PBS and then incubated in a 1:500 dilution of a rabbit polyclonal hyperimmune
serum to RRV in PBS for 30 min at 4°C, washed twice with PBS, and then
incubated with a 1:100 dilution of fluorescein-conjugated anti-rabbit immuno-
globulin G (Kirkegaard & Perry, Gaithersburg, Md.) in PBS for 30 min at 4°C.
After the incubation period, the number of antibody binding cells was deter-
mined by flow cytometry with the instrumentation described above.
RESULTS
Viability of RRV-infected Caco-2 cells and evaluation of the
percentage of cells infected. We used human cDNA microar-
rays to study the global transcriptional response of cells in-
fected with rotavirus. We chose the human intestinal cell line
Caco-2 (16) as a model that would mimic characteristics of
rotavirus replication in vivo. Caco-2 cells were derived from a
human colon adenocarcinoma and display several characteris-
tics of mature enterocytes, such as cellular polarization, devel-
opment of an apical brush border membrane, and expression
of intestinal hydrolases on the apical domain (62). In addition,
Caco-2 cells have been used to study the interaction of several
enteropathogens with the intestine (39, 40, 54), and most ro-
tavirus strains, including our laboratory strain RRV, grow ef-
ficiently in Caco-2 cells (32, 55).
We choose 16 h as a primary time point to evaluate the
cellular transcriptional response to rotavirus infection because
Caco-2 cells are lysed at late times after infection (after 24 to
48 h) (29, 43). To establish the viability of the cells at 16 hpi
under our experimental conditions, Caco-2 cells were grown in
monolayers and, 15 days postseeding, were mock or RRV
infected at an MOI of 30. At 16 hpi cellular viability was
assessed by measuring the percentage of live and dead cells, as
described in Materials and Methods. A fraction of the cells
were killed by permeabilization with 70% methanol for 20 min
and used as a positive control for dead cells. The percentage of
living cells was determined by the presence of intracellular
esterase activity which was detected by measuring the conver-
sion of calcein AM to calcein by fluorescence-activated cell
sorting (FACS) analysis. The percentage of dead cells was
determined by membrane damage, which was detected by
measuring the binding of ethidium homodimer (EthD-1, an
impermeable fluorescent dye) to nucleic acids by FACS anal-
ysis (Molecular Probes Live/Dead Viability/Cytotoxicity Kit,
L-3224). As can be seen in Fig. 1b and d, mock- and RRV-
infected cells look similar at 16 hpi; 77% of the mock-infected
and 78% of the RRV-infected cells were positive for intracel-
lular esterase activity and negative for EthD-1 staining (lower
right quadrant). In contrast, 97% of the methanol treated
cells were positive for EthD-1 and negative for calcein staining
(upper left quadrant, Fig. 1a and c). Taken together, these
FIG. 1. (a to d) Viability of Caco-2 cells 16 h after rotavirus infec-
tion. Caco-2 cells were grown as monolayers and, at 15 days post-
seeding, were mock (a and b) or RRV (c and d) infected at an MOI of
30. At 16 hpi the cell viability was assessed by measuring the percent-
age of live and dead cells by FACS analysis. Live cells were identified
by the presence of intracellular esterase activity, which was detected by
treating the cells with calcein-AM. Dead cells were identified by mea-
suring membrane damage, which was detected by treating the cells
with ethidium homodimer (EthD-1). A fraction of the cells (a and c)
were killed by permeabilization with 70% methanol for 20 min, as
positive control for dead cells. (e to h) A percentage of cells were
infected with RRV. Caco-2 cells were grown as monolayers and, at 15
days postseeding, were mock (e and f) or RRV (g and h) infected at an
MOI of 20. At 16 hpi the cells were permeabilized, stained with a
rabbit polyclonal anti-rotavirus serum (f and h) or mock stained (e and
g), further stained with an anti-rabbit FITC-conjugated immunoglob-
ulin, and subjected to FACS analysis.
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results indicate that at 16 h after rotavirus infection Caco-2
cells were alive.
We also determined the percentage of cells infected under
our conditions. Caco-2 cells were mock or RRV infected at an
MOI of 20; at 16 hpi the cells were fixed and stained with a
rabbit polyclonal antiserum against RRV as described in Ma-
terials and Methods and subjected to FACS analysis. As can be
seen in Fig. 1e to h, 75% of the inoculated cells stained
positively for RRV antigen. Hence, mRNA from infected cells
used for hybridization analysis was derived from a population
of living cells in which 75% were infected. Infection with
MOIs of 50 and 100 only produced a 5% increment in the
percentage of infected cells (data not shown).
Rotavirus infection induces changes in cellular gene expres-
sion of Caco-2 cells. Our approach for studying the cellular
transcriptional response during rotavirus infection consisted of
comparing the relative abundance of specific poly(A) mRNA
in infected cells to the same specific poly(A) mRNA from
mock-infected cells by using cDNA microarrays containing
thousands of cellular genes (see Materials and Methods). Pre-
liminary experiments with Caco-2 cells from different passage
levels or different flasks at the same passage level under the
same culture conditions showed some variability in the pattern
of mRNA expression (data not shown). In order to specifically
attribute transcriptional changes to virus infection (and not to
background variability), we determined the background tran-
scriptional variability of our cell culture system. To do this, we
compared mock-infected cells versus mock-infected cells at 1
hpi, mock-infected cells versus mock-infected cells at 16 hpi,
and RRV-infected cells versus RRV-infected cells at 16 hpi
Each comparison was repeated one or two times (see Table 1).
Representative plots of some of these comparisons are shown
in Fig. 2.
We analyzed the number and percentage of gene transcripts
that varied by 2-fold in this series of comparisons in order to
identify the background rate of transcriptional variation in our
system. As can be seen (Fig. 2a and c), when mock-infected
cells were compared to mock-infected cells (at 1 and 16 h) and
RRV-infected cells were compared to RRV-infected cells at 16
hpi (Fig. 2e), few transcripts varied by2-fold: the results were
0.9, 1.15, 1.68, 1.71, and 2.2% for the five control hybridizations
presented in Table 1. This variability could be due to the
variability in the microarray technique (extraction and purifi-
cation of the mRNA, cDNA synthesis and labeling, hybridiza-
tion and/or signal detection) or to natural transcriptional vari-
ability that may occur in Caco-2 cells in culture. When we
compared RRV-infected cells versus mock-infected cells at 1
hpi (Fig. 2b), 1.0, 1.2, and 1.8% of the genes varied 2-fold
(for the three RRV versus mock hybridizations in Table 1), a
finding which was similar to the background rate. However,
when we compared RRV-infected cells versus mock-infected
cells at 16 hpi, 8.6, 8.9, and 11% (for the three RRV versus
mock hybridizations in Table 1) of the gene transcripts varied
2-fold (Fig. 2d). These results indicate that rotavirus infec-
tion induces changes in cellular gene expression at 16 h after
infection.
Genes that respond to RRV infection. It was clear from our
analysis (Fig. 2a and c) that there is an intrinsic variability in
our cell culture system, since there were some changes in
cellular gene expression that were detected when we compared
RNA extractions from cells treated identically. In order to
identify genes that specifically responded to RRV infection, we
performed independent infections with corresponding inde-
pendent controls (see Materials and Methods and Table 1).
We undertook a series of steps to identify genes that re-
sponded specifically to RRV infection. First, we selected genes
that passed the filter criteria (see Materials and Methods) and
did not change by 1.4-fold in control comparisons (mock
versus mock and infection versus infection; Table 1). We then
determined how many of these genes passed the filter criteria
in the experimental comparisons (RRV versus mock) at 1 and
16 h and how many of these were up- or downregulated.
Between 35.1 and 47.7% of the human printed array ele-
ments (13,506 to 18,339 of 38,432 human printed elements)
were suitable for analysis after initial filtration. After the elim-
ination of genes that varied by 1.4-fold in the control com-
parisons, we identified a list of 8,528 genes for the 1 h time
point and 9,171 genes for the 16 h time point that were suitable
for further study. These genes were analyzed in the infectious
comparisons (RRV versus mock). Of the 8,528 genes, 7,263
gave a signal above background in the 1-h infection compari-
sons (RRV versus mock) and, of the 9,171 genes from the 16 h
time point, 8,575 gave a signal above the background in the
16-h infection comparisons (RRV versus mock).
A similar analysis with the nonhuman genes (the arrays
contain 448 nonhuman genes from yeast and bacteria, see
Materials and Methods) was also performed. Only one gene
(0.22%) passed the filter criteria in 50% of the 11 arrays
examined.
We used the following rationale to select the threshold for
classifying genes as up- or downregulated. First, we wanted to
ensure that genes identified were actually regulated by infec-
tion and, for this purpose, the higher the fold change selected
as a threshold, the higher the likelihood of significance. How-
ever, we do not yet know what significance to assign to lower-
level changes in transcription. Therefore, we arbitrarily chose
to classify genes whose transcriptional level changed by 2-
fold in at least two of the three experimental hybridizations
(Table 1) as rotavirus-regulated genes. Responses of 2-fold
have also been used as selection criteria by others to identify
transcriptionally regulated genes by microarray analysis (7, 20,
27). As described above, none of the selected genes varied by
1.4-fold in any of the control comparisons.
Five hundred and eight genes were up- or downregulated by
2-fold at 16 hpi (Fig. 3). A similar analysis at the 1 h time
point disclosed only one gene which changed by 2-fold (the
potassium large conductance Ca2-activated channel). Several
observations can be made from this analysis. It is clear that
after 1 h of rotavirus infection, Caco-2 cells showed a very
limited transcriptional response to infection (only one gene
was transcriptionaly regulated 2-fold). In contrast, at 16 hpi,
579 array elements, representing 511 genes (some genes were
printed more than once) were up- or downregulated. Of these,
375 (73.4%) were upregulated and 133 (26.02%) were down-
regulated. Of the 579 array elements identified, only three
(0.58%) gave inconsistent results, being upregulated in one
hybridization, and downregulated in the other hybridization.
Of note, the fluorochrome signal used for labeling did not
affect the results, since labeling the cDNAs in the opposite way
(cDNA from mock-infected cells labeled with Cy5 and cDNA
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from RRV-infected cells with Cy3) had very little effect (data
not shown). The 579 array elements that passed the twofold
change criteria represent 6.7% of the total analyzable popula-
tion (8,575 genes).
An examination of the genes in Fig. 3 shows variation in the
intensities of the green and red signals obtained. This reflects
different levels of up- and downregulation among the various
genes. We analyzed the level of change by identifying the genes
that changed their level of expression between 2- and 4-fold
and those that changed by 4-fold at 16 hpi. It is clear that
changes between 2- and 4-fold are most frequent (Fig. 4); 463
genes were regulated between 2- and 4-fold, and only 45 genes
were regulated 4-fold. Of these, 42 were upregulated, and 3
were downregulated.
The results observed were consistent across infection com-
parisons by using several types of analysis. The regulated genes
were initially identified by setting the program to select genes
that were up- or downregulated 2-fold in at least two of the
three experimental hybridizations (Table 1). However, 304 of
the 576 array elements (52%) or 266 of the 508 genes were
regulated 2-fold in all three experimental hybridizations (hy-
bridizations 4, 5, and 6; Table 1) and, of the remaining array
elements (272), 180 were regulated 1.6-fold in the third hy-
bridization. This means that 84% of the genes showed the
same transcriptional regulation in the three separate hybrid-
izations (hybridizations 4, 5, and 6, Table 1). Of the remaining
16% genes, half were not analyzable in the third hybridization.
Only three genes (0.04% of the total analyzed population)
FIG. 2. Hybridization results from mock-infected cells versus mock-infected cells (a and c), RRV-infected cells versus RRV-infected cells (e),
and RRV-infected cells versus mock-infected cells (b and d) at 1 hpi (a and b) and 16 hpi (c, d, and e). The x and y axes represent the intensity
for the green fluorescent dye Cy3 and the normalized intensity of the red fluorescent dye Cy5, respectively. The solid lines represent no change
in the level of gene expression, and the dashed lines indicate a twofold change in the transcriptional response. The percentage of genes that
changed more than twofold is indicated for each panel.
VOL. 76, 2002 GENE EXPRESSION IN CELLS AFTER ROTAVIRUS INFECTION 4471
FIG. 3. Cluster analysis of genes that were differentially expressed after 16 h of RRV infection. Each horizontal row represents a single cDNA,
and each vertical column represents a single microarray hybridization. The results are presented in color display; each square represents the ratio
of hybridization signal of labeled cDNA prepared from the mRNA of RRV-infected or mock-infected cells relative to mock-infected cells. Red
squares denote upregulated genes, green squares denote downregulation, black squares denote no significant change in the level of gene
expression, and gray squares denote missing data. The colored scale for the level of up- or downregulation is depicted at the bottom. The first three
columns correspond to control hybridizations (mock infected versus mock infected or RRV infected versus RRV infected), and the last three
columns correspond to experimental hybridizations (RRV infected versus mock infected). The genes shown are those whose transcript levels varied
2-fold in at least two of the three experimental comparisons. Some regions are amplified at the right to show the name and the expression profile
of selected genes.
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showed inconsistent regulation, indicating upregulation in one
experimental hybridization and downregulation in the other.
From this initial analysis we conclude that rotavirus infection
induces changes in the levels of 6.7% of the cellular analyzable
genes in Caco-2 cells at 16 hpi, and the majority of these
transcriptional responses correspond to upregulation of genes.
The majority of the changes in cellular gene expression
occur at late time points after infection. The results of the
microarray analysis at 1 and 16 hpi showed a significant differ-
ence in the transcriptional response between the two time
points, from one gene at 1 hpi to 508 genes at 16 hpi. To
determine whether the genes responding at 16 h were regu-
lated at earlier times during infection, we carried out an addi-
tional time course experiment in which mock- or RRV-in-
fected Caco-2 cells were harvested at 1, 6, 12, and 24 h after
infection. Labeled cDNAs synthesized from mRNA from
RRV-infected cells at each time point were mixed with labeled
cDNAs synthesized from mRNA from mock-infected cells at
the corresponding time points (RRV 1 h versus mock 1 h,
RRV 6 h versus mock 6 h, etc.). We also carried out control
comparisons by mixing labeled cDNAs from mock-infected
cells with labeled cDNAs from the same batch of mock-
infected cells (mock versus mock hybridization). The mixed
cDNAs were hybridized to microarrays and analyzed as in the
first series of hybridizations (Table 1), the difference being that
in the time course experiment, we used only one infection
sample and one mock-infected sample for each time point.
We focused our analysis on the genes that were regulated by
2-fold in the first experiment (Fig. 3 and Table 3) at 16 hpi to
find out whether the changes observed at 16 hpi could be
detected at earlier time points. We eliminated genes that
changed their level of expression by 1.4-fold or more in the
control comparison of the time course experiment. We next
selected 227 genes that passed the filtering criteria (described
in Materials and Methods) for all time points (i.e., control and
1, 6, 12, and 24 h). Cluster analysis was then performed with
the five hybridizations of the time course experiments and one
(RRV versus control) hybridization from the 16-h time point.
Figure 5 shows the pattern of expression for selected genes
that were up- or downregulated 2-fold in at least two hybrid-
izations in the time course analysis. A common pattern was
found in the time course study; the number of up- and down-
regulated genes increased with the time from infection, start-
ing with very few genes after 1 h and reaching the maximum at
the latest time points (16 and 24 hpi). In the time course
experiment, up- and downregulated genes were observed, and
again upregulated genes were most frequent (Fig. 5). Of 227
genes examined, 3 were transcriptionally regulated (2-fold
change) at 6 hpi and 33 genes were transcriptionally regulated
at 12 hpi (Table 2). It is clear from these results that most of
the responses observed at 16 hpi in the first experiment (Fig. 3,
Table 1) became detectable late, i.e., at 12 hpi or later.
Grouping of genes according to their biological function.
We identified 375 upregulated and 133 downregulated genes
following rotavirus infection in our primary analysis. A com-
plete list of these genes is presented in Table 3. In an attempt
to facilitate the analysis of our data, we grouped the differen-
tially regulated genes according to known biological functions.
However, the classification of genes to specific cellular func-
tions is difficult because many genes participate in more than
one biological process. We listed the regulated genes in only a
single functional category for simplicity. Only two genes listed
in Table 3 have been previously described as rotavirus-induced
genes (endoplasmin and RANTES). The regulation of some
genes involved in calcium homeostasis, cytoskeleton structure,
IFN regulation, and stress response were anticipated since
previous data demonstrated the relationship between rotavirus
infection and these biological processes (5, 6, 11, 44, 46, 58).
Genes associated with other important cell functions, including
cell cycle and proliferation, protein degradation, viral recep-
tors, and membrane transporters are also regulated in re-
sponse to rotavirus infection (Table 3).
DISCUSSION
We investigated the transcriptional changes in Caco-2 cells
after RRV infection in order to better understand the cell
response to this important enteric pathogen. We used Caco-2
cells as a host cell to try to mimic characteristics of rotavirus
replication in the human gut. We used an animal strain of
rotavirus, RRV, because this strain replicates well in tissue-
cultured cells and because RRV has been given to many hun-
dreds of thousands of people in the form of a live attenuated
vaccine. Human strains of rotavirus do not replicate as well as
many animal strains in cell culture. Given that Caco-2 cells are
lysed late after infection (29, 43), we performed our analysis of
the cellular transcriptional response at 1 and 16 hpi as early
and intermediate time points in the replication cycle. We also
analyzed the transcriptional response over a broader time
course of infection (1, 6, 12, and 24 hpi).
We learned that there are changes in the amount of mRNA
transcripts present in RRV-infected Caco-2 cells compared to
mock-infected cells, with 576 of 8,575 analyzable array ele-
ments changing by 2-fold at 16 hpi. These changes involve
both the upregulation and the downregulation of specific gene
transcripts, with a majority of the changes being upregulation.
The majority of the changes occurred at times at or after 12 h
FIG. 4. Different level of gene transcription in Caco-2 cells 16 h
after RRV infection. Up- or downregulated genes were classified ac-
cording to their level of transcription. The categories indicated start
from genes that changed between 2- and 4-fold and finish with genes
that changed 8-fold. The fold change is the normalized red intensity/
green intensity ratio. This ratio represents the abundance of transcript
in infected cells relative to mock-infected cells at 16 hpi. For down-
regulated genes, the corresponding red/green ratio is the reciprocal of
the fold change indicated.
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FIG. 5. Cluster analysis of selected genes that were significantly up- or downregulated at 16 hpi during a time course of rotavirus infection. An
array from the 16-h time point of the first experiment is included for comparison. Genes that passed filtering criteria in all of the hybridizations
and were not regulated by 1.4-fold in the control hybridization were studied. Of the selected genes, genes that were regulated by 2-fold in at
least two arrays are shown. The color coding is the same as in Fig. 3.
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of infection, with an increasing number of genes identified as
infection proceeded. Among the upregulated genes, we found
different levels of regulation with most genes changing be-
tween 2- and 4-fold, and only 42 genes being upregulated by
4-fold in our analysis. Rotavirus infection regulates the ex-
pression of a number of genes with related functions, including
genes coding for cellular structural proteins, stress-related pro-
teins, IFN-related genes, Ca2-related proteins, and transcrip-
tional and translational regulators. In addition, many genes
previously unknown to be related to rotavirus or other viral
infections were found to be modulated.
One of our concerns was to optimize our ability to identify
genes regulated by rotavirus infection as opposed to other
causes of transcriptional variation under our experimental con-
ditions. Variability due to mRNA extraction and purification,
cDNA synthesis, labeling and purification, and signal detection
could generate changes in the amount of mRNA detected.
Also, natural transcriptional variation is likely to occur in
Caco-2 cells during culture. An analysis of the sources of back-
ground transcriptional variability was not carried out in our
studies. We did, however, utilize a variety of strategies to
minimize background variability. We used duplicate or tripli-
cate assays for each condition tested. For example, two sets of
flasks were infected with RRV and harvested at 16 hpi, and
mRNA from each set of flasks was extracted and tested sepa-
rately and compared to three separate control flasks. Fluores-
cently labeled cDNAs were synthesized by using each separate
extracted mRNA. In this way we obtained independent sam-
ples of fluorescently labeled cDNAs from RRV-infected cells.
In the same way, we obtained three samples of fluorecently
labeled cDNAs from mock-infected cells. These cDNAs were
mixed by using different combinations (mock versus mock,
RRV versus RRV, and RRV versus mock; Table 1) and hy-
bridized to microarrays in order to increase the number of
replicate experiments analyzed.
The analysis of the control arrays (mock versus mock and
RRV versus RRV; Fig. 2 and results not shown) identified
genes that were variable under similar experimental condi-
tions. We used this information to eliminate from the analysis
any transcript demonstrating a1.4-fold change in at least one
of these control hybridizations. This procedure assumes that
the eliminated genes changed because they were inherently
variable; however, we did not directly prove this. We also chose
to use stringent selection criteria to identify a list of analyzable
genes (a complete list of the data may be obtained at http:
//genome-www.stanford.edu/microarray) (52). We first se-
lected only the genes that did not vary by 1.4-fold in the
control comparisons. We then selected only genes having a
2-fold change in at least two of the three (RRV versus mock)
hybridizations (Table 1). Hence, all of the 579 identified genes
changed their level of transcriptional expression by 2-fold in
at least two of the three RRV versus mock hybridizations and
did not change their expression level by 1.4-fold in any of the
control hybridizations. It is important to add that the majority
of the genes (84%) which changed2-fold in two (RRV versus
mock) hybridizations also changed similarly in the third hy-
bridization, although in some cases only by a 1.6-fold criteria
(Fig. 3). Only 3 of the 579 identified genes gave divergent
results in the analysis (i.e., upregulated in one array and down-
regulated in another) which was 0.034% of the analyzed
population.
Regarding the 448 nonhuman genes (yeast and bacterial
genes) spotted in the arrays as negative controls, only one
passed the filter criteria in 50% of all of the hybridizations,
further demonstrating the specificity of the hybridization.
Although general interpretation of microarray analysis fre-
quently assumes that the detection and quantification of thou-
sands of transcripts directly reflects actual changes in gene
expression level, one should remember that the regulation of
cellular mRNA decay rates is also an important control point
in determining transcript abundance and gene expression.
A substantial difference in the number of regulated genes
was observed when comparing the response at 1 and 16 hpi
(Fig. 2, 3, and 5). A time course experiment was carried out to
determine when during the infection the observed transcrip-
tional responses occurred. Although the time course experi-
TABLE 2. Genes up- or downregulated by 2-fold at 6 and/or 12 h
after rotavirus infection (from the 508 genes that
were regulated at 16 hpi)
Time postinfection (h) and gene Foldchangea
6
ESTsb...................................................................................................... 0.5
Tax interaction protein 1..................................................................... 2.08
Nucleolar protein p40; homolog of EBNA1-binding protein......... 2.12
12
Nuclear receptor subfamily 2, group F, member 2.......................... 0.32
Homo sapiens mRNA; cDNA DKFZp586F1322 ............................. 0.38
Hypothetical protein DKFZp566G1424 ............................................ 0.39
Human DNA sequence from clone 747H23 on chromosome
6q13-15............................................................................................... 0.37
Homo sapiens cDNA: FLJ21278 fis, clone COL01832 .................... 0.48
Alpha-methylacyl-coenzyme A racemase .......................................... 0.39
Homo sapiens cDNA FLJ13604 fis, clone PLACE1010401 ............ 0.48
Cyclin-dependent kinase inhibitor 1B (p27, Kip1) .......................... 0.41
Epidermal growth factor receptor (avian erythroblastic
leukemia viral (v-erb-b) oncogene homolog) ............................... 2.02
ESTs ....................................................................................................... 2.18
Cartilage linking protein 1 .................................................................. 2.35
Steroid-5-alpha-reductase, alpha-polypeptide 1 (3-oxo-5-alpha-
steroid-delta-4-dehydrogenase-alpha-1)......................................... 2.71
Homo sapiens cDNA FLJ20153 fis, clone COL08656 ..................... 2.58
Putative b, b-carotene-9,10-dioxygenase ......................................... 2.53
Thioredoxin reductase 1 ...................................................................... 2.87
Splicing factor, arginine/serine-rich 3 ................................................ 2.14
Molecule possessing ankyrin repeats induced by
lipopolysaccharide (MAIL), homolog of mouse .......................... 4.76
IFN-related developmental regulator 1............................................. 2.18
Nuclear factor kappa, light polypeptide ............................................ 2.04
v-fos FBJ murine osteosarcoma viral oncogene homolog ..............15.6
Chromosome 21 open reading frame 50........................................... 3.67
Protein kinase H1l; small stress protein-like protein HSP22 ......... 2.04
Heat shock 70-kDa protein-like 1 ...................................................... 2.57
Caveolin 2.............................................................................................. 2.10
v-jun avian sarcoma virus 17 oncogene homolog............................. 4.9
Arginine-rich, mutated in early-stage tumors ................................... 2.76
Solute carrier family 3 (activators of dibasic and neutral
amino acid transport), member 2................................................... 2.52
KIAA0005 gene product ..................................................................... 2.33
E74-like factor 3 ................................................................................... 2.23
Serum-inducible kinase........................................................................ 2.41
Ectodermal-neural cortex (with BTB-like domain) ......................... 2.03
Eukaryotic translation initiation factor 2B, subunit
2 (beta, 39 kDa) ............................................................................... 2.18
Transgelin .............................................................................................. 2.78
a Values of 2 and 0.5 correspond to up- and downregulated genes, respec-
tively.
b ESTs, expressed sequence tags.
VOL. 76, 2002 GENE EXPRESSION IN CELLS AFTER ROTAVIRUS INFECTION 4475
TABLE 3. List of transcriptionally regulated genes in Caco-2 cells after 16 h of RRV infection
Function and
gene namea
SwissProt
accession
no.b
FCc
Function and
gene namea
SwissProt
accession
no.b
FCc Function andgene namea
SwissProt
accession
no.b
FCc
Protein modification and degradation
*Itchy E3 ubiquitin protein ligase P46934 2.6
Ubiquitin ligase SMURF2 P39940 2.2
*Yeast homolog ubiquitin ligase Rsp5 P46935 3.5
Proteasome 26S subunit ATPase 3 P17980 2
*Matrix metalloproteinase 14 P50281 3.3
Disintegrin and metalloproteinase
domain 9
Q61072 2.1
*hnRNP methyltransferase 1-like 2 Q99873 2.4
Cathepsin D (lysosomal aspartyl
protease)
P07339 8.8
*Lectin-like oxidized-LDL receptor 1 P78380 3.8
*Kallikrein 6 Q92876 2.3
*Ariadne (Drosophila) homolog P36113 2.4
*Ubc6p homolog P51965 2.5
Transmembrane protease, serine 2 O15393 0.5
Transcriptional regulators
*Transcription factor Dp-2 Q14188 2.5
*FOS P01100 6.6
*Fos-like antigen 1 P15407 15
*JUN P05412 17
*Activating transcription factor 4 P18848 2.7
NFB1 P19838 2.4
*NFB1E O00221 5.4
*E74-like factor 3 P78545 3.8
Thyroid hormone receptor interactor 8 Q15652 2.6
Far upstream element binding protein 1 P57722 2.3
Bromodomain adjacent to zinc-finger
domain 1A
Q9UIG1 2.4
*MAIL Q9BYH8 6.4
*Cyclic AMP-responsive
element modulator
Q03060 5.4
*Core promoter element binding Q99612 4.3
Zinc finger protein (LOC51042)
(IMAGE: 471200)
2.8
*TGFB-inducible early growth response Q13118 2.9
*RNA polymerase II elongation factor
ELL2
O00472 2.9
La ribonucleoprotein P05455 2.4
Zinc finger protein 9 P20694 2.1
Zinc finger protein 216 O76080 2.3
Zinc finger protein 313 ZNF313 2.6
*DNA damage-inducible transcript 3 P35638 2.5
Nuclear receptor coactivator 2 P41738 0.4
*Transcriptional intermediary factor 1 Q64127 0.4
Zinc fingers and homeoboxes 1 Q9UKY1 0.3
*p300/CBP-associated factor P13941 0.3
*MAX-interacting protein 1 P50539 0.4
*Nuclear receptor subfamily 2, group F,
member 2
P24468 0.3
Apoptosis
Programmed cell death 5 P56812 2.8
Apoptosis antagonizing transcription factor Q9UNX5 2.2
*Cytochrome c P00009 2.6
*TNF-	-induced protein 3 P21580 6.5
*Immediate-early response 3 P46695 3.8
*Baculoviral IAP repeat-containing 3 Q13490 3.8
*Insulin-like growth factor
receptor
P08069 3.1
SERPINB2 P05120 5.7
*SH3GLB2 Q99961 0.5
Translation machinery
EIF1A Q60872 2.4
EIF2S2 P20042 2.3
EIF2B2 P49770 2.4
EIF3S1 O75822 2.5
EIF3S5 O00303 2.3
*EIF4A1 P04765 2.6
SUI1 Q9UNQ9 2.4
Alanine-tRNA synthetase P49588 2.2
Lysyl-tRNA synthetase Q15046 2.1
Phenylalanyl-tRNA synthetase 
 Q9NSD9 2.3
Tyrosyl-tRNA synthetase P54577 2.1
*RNA helicase P40562 4.4
DEAD/H box polypeptide 3 O00571 2.3
*DEAD/H box polypeptide 16 O60231 2.4
DEAD/H box polypeptide 21 Q64060 2.3
DEAD/H box polypeptide Y chromosome O15523 2.2
*hqp0256 protein P38712 2.5
*Nucleophosmin 1 P06748 2.6
Signal recognition particle, 19 kDa P09132 2.2
Cytoskeleton and cell structure
*Actin alpha cardiac muscle P04270 3.9
*Actin alpha-2 smooth muscle, aorta P03996 3.3
Actinin alpha-4 P08640 2.3
Actin related protein 2/3 complex subunit 2 O15144 2.1
Calponin 3 acidic isoform Q15417 2.6
Caldesmon 1 Q05682 2.9
Continued on following page
Ectodermal-neural cortex O14682 2.2
Thymosin beta-4 Y chromosome O14604 3.1
*Lymphocyte cytosolic protein 1 P13796 3.3
*Vimentin P08670 2.1
*Keratin 4 P19013 3
*Keratin 5 P13647 3.6
Keratin 15 P19012 2.4
*Syndecan binding protein O17583 2.9
Myosin light polypeptide 1 P05976 2.2
Tropomyosin 4 P07226 2.6
Bystin-like Q13895 2.5
*Small prolin-rich protein 1B P22528 7.1
*Testin O35115 2.9
Epithelial protein lost in neoplasma 
 Q9UHB6 2.6
ras homolog gene family member E P52199 2.1
Rho GDP dissociation inhibitor (GDI) 
 P52566 2.7
Rap1b member of RAS oncogene family P09526 2.1
Protein regulator of cytokinesis 1 O43663 2.2
*Microtubule associated protein
member 1
P40013 2.6
Cell adhesion and intercellular junctions
*Cadherin 5 type 2, VE-cadherin P33151 3.4
Protocadherin 18 Q9HCL0 2.6
*CEA1 P13688 3.4
*CEA5 P06731 2.2
Catenin alpha-like 1 Q61301 2.4
Vinculin P18206 2.5
*Epithelial V-like antigen 1 O60487 3.4
Vascular cell adhesion molecule 1 P19320 2.2
*Thrombospondin 1 P07996 3.9
Cartilage linking protein 1 P10915 2.3
Occluding Q16625 2
*Catenin delta 1 O60716 0.4
Cell cycle
Cyclin C P24863 2
*Cyclin D1 P24385 2.9
Cyclin E1 P24864 2.1
*Cyclin L ania-6a Q9UK58 5.1
*Cyclin-dependent kinase 7 P50613 2.4
Pescadillo homolog 1 P54258 2.1
*BTG family member 2 P78543 2.5
*Cyclin G2 Q16589 0.3
Cyclin-dependent kinase inhibitor 1B P46527 0.5
*Putative lymphocyte G0/G1 switch gene P27469 0.2
Damage-specific DNA binding protein 1 Q16531 0.4
*Ataxia telangiectasia mutated P42346 0.4
Cellular development and differentiation
*Retinoic acid induced 3 O95357 5.1
*Fibroblast growth factor 7 P21781 2.7
*Enhancer filamentation 1 Q14511 2.3
Oncogene TC21 P10833 2.2
*N-myc downstream regulated Q92597 3
*Ras association (RalGDS/AF-6)
domain family 1
O60539 2.2
*Tax interaction protein 1 O14907 2.8
*Nucleolar protein p40 Q99848 3
*Epithelial membrane protein 1 P54849 4.2
RNA processing and modification
*U3 snoRNP-associated 55-kDa protein O43818 2.4
*Nucleolar protein 1,120 kDa P46087 2.7
Splicing factor arginine/serine-rich 7 Q16629 2.2
Splicing factor arginine/serine-rich 3 P23152 2.3
*Heterogeneous ribonucleoprotein A/B Q99383 2.3
Heterogeneous ribonucleoprotein C P07910 2.7
*Phorbolin Q9UH17 2.8
Kinases and phosphatases
NF-kappa-
-induced kinase Q99558 2.4
PCTAIRE protein kinase 2 Q00537 2
*Serum-inducible kinase Q9NYY3 3.2
Serum/glucocorticoid regulated kinase O00141 2.5
Protein tyrosine kinase 2
 Q14289 2.5
Kinase insert domain receptor P35968 2.7
Uridine monophosphate kinase P52623 2.3
Hexokinase 2 P52789 2.6
Ethanolamine kinase (EKI1) Q9HBU6 2.2
Tyrosine 3-monooxygenase P29312 2.5
*Cyclic AMP-dependent protein
kinase inhibitor 

P27775 2.5
Protein phosphatase 2A, 
-isoform P11082 2
*MKP-1 like protein tyrosine phos-
phatase
P28563 2.8
*Dual specificity phosphatase 6 Q16828 2.6
Pyrophosphatase inorganic Q15181 2.3
*MINPP1 (IMAGE: 592630) 0.4
Lipid biosynthesis and drug
metabolism
*Dual adaptor of phosphotyrosine Q9UN19 5.8
*Phospholipid scramblase 1 P47140 2.5
*Niemann-Pick disease type C1 O15118 2.4
Stomatin-like 1 Q9UBI4 2.1
*Cytochrome b5 reductase b5R.2 P20070 3.6
*Fatty acid coenzyme A ligase
long-chain 4
O60488 2.7
*Alpha-methylacyl-coenzyme A
racemase
P70473 0.5
*CTP synthase P17812 3.3
Cytochrome P450 subfamily IIB
polypeptide 6
P20813 2.3
Stress response
*HspC030 Q9Y6D0 2.4
*Hsp40 Q9QYJ3 7.2
*Hsp70 protein-like 1 P34931 6.7
*Tumor rejection antigen 1 P14625 2.7
*GrpE-like protein cochaperone P97576 2.5
*Sperm-associated antigen 1 P50503 2.6
*Crystalline alpha B O43416 4.3
*Small stress protein-like protein Hsp22 Q9UJY1 4.7
*Chaperonin containing TCP1 subunit 5ε P48643 2.8
Chaperonin containing TCP1 subunit 4 P50991 2.3
*Chaperonin containing TCP1 subunit
6A (zeta 1)
P40227 2.2
Peptidylprolyl isomerase B P23284 2.2
Oxidative-stress responsive 1 Q9Z1W9 2.3
Clusterin P10909 2.2
Heat shock 70-kDa protein 1B P08107 0.4
IFN response
*IFN-related developmental regulator 1 O00458 6.3
*IFN-regulatory factor 2 P14316 2.6
*2-5-oligo(A) synthetase 1 (OAS1) P00973 5
IFN induced with tetraticopeptide
repeats 1
P09914 3.8
IFN--inducible protein 16 Q16666 2.7
*Guanylate binding protein 1, 67 kDa P32455 6.2
Immune response
Small inducible cytokine A5 (RANTES) P13501 2.6
*IL-2 receptor beta P14784 2.9
*IL-1 receptor accessory protein Q02955 2.4
*UL16 binding protein 2 Q9BZM5 3.5
Pregnancy-specific 
-1-glycoprotein 1 P11464 3
Chornichon-like O95406 2.1
*Prostaglandin-endoperoxide synthase 2 P35354 3.5
*Leukotriene A4 hydrolase P09960 2.7
*Spermine synthase P52788 3.4
*Spermidine/spermine N1-acetyltrans-
ferase
P21673 6.7
*S-Adenosylmethionine decarboxylase 1 P17707 2.6
*Amiloride-binding protein 1 P19801 0.4
Membrane transporters
K channel subfamily K member 1 O00180 2.2
*Zinc/iron regulated transporter-like Q9BTV0 2.4
*ATP-binding cassette subfamily G
member 2
Q9UNQ0 2.9
Solute carrier family 2 member 3 P11169 2.5
Solute carrier family 26 member 3 P40879 2.2
Kynurenine 3-monooxygenase Q9H1Y5 2
Transferrin receptor P02786 2.3
Ferredoxin 1 P10109 2.1
*Thioredoxin reductase 1 Q16881 2.5
*IMP dehydrogenase 2 P12268 2.3
*Steroid-5-alpha reductase, alpha
polypeptide 1
P18405 6.4
*Methylene tetrahydrofolate dehydro-
genase 2
P36776 2.8
*K voltage-gated channel subfamily
H member3
Q12809 0.4
*Solute carrier family 11 member 3 Q9NRL0 0.3
*Duodenal cytochrome b P49447 0.3
Signal transduction
*Integrin-	6 P23229 2.7
*Plasminogen activator urokinase
receptor
Q03405 4.7
Tetraspan NET-7 O95858 2.7
Zinc finger protein 259 O75312 2.3
SBBI31 protein (IMAGE: 429470) 2.3
*TNF receptor superfamily member 11b P20333 4.4
*Oncogene ERBB3 P21860 0.4
Vav 3 oncogene Q9UKW4 0.4
*Ral guanine nucleotide exchange factor Q9NZ16 0.4
Epidermal growth factor receptor P00533 0.5
Vesicle formation and intracellular
transport
*Caveolin 1 Q03135 3
*Caveolin 2 P51636 3.6
*PI-clathrin assembly protein Q13492 2.6
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TABLE 3—Continued
Function and
gene namea
SwissProt
accession
no.b
FCc
Function and
gene namea
SwissProt
accession
no.b
FCc Function andgene namea
SwissProt
accession
no.b
FCc
Adaptor-related protein complex 3, 
2
subunit
P21851 2.2
*ADP-ribosylation factor binding
protein GGA3
P22892 2.2
Myosin X P19524 2
*RAB31, RAS oncogene family Q13636 2.7
Syntaxin 3A Q13277 2.5
*Myomegalin P25386 0.4
CNS-specific functions and neuropeptides
*Neuronal protein (NP25) Q9UI15 6.3
*SRY-box 11 (SOX11) P35716 6.4
*Dunce-like phosphodiesterase E4 Q07343 3.4
*Gamma-aminobutyric acid A receptor 2 P18507 2.8
Huntington-associated protein inter-
acting protein
O60229 2.2
*Cholecystokinin P06307 4.4
*Glycoprotein hormones 	 polypeptide P01215 14.7
*Gamma-aminobutyric acid A receptor ε P78334 0.4
Enzymes
N-Acetylneuraminic acid phosphatase
synthase
Q12999 2.3
Iduronidase alpha L P35475 2.1
*Rab geranylgeranyltransferase, 
 subunit P53611 2.7
Phosphorylase, glycogen; liver P06737 2.1
Enolase 1, alpha P06733 2.2
*Glutathione S-transferase A2 P09210 2.6
*Glutathione S-transferase A3 Q16772 2.8
Leucine aminopeptidase P28838 2.4
*Putative b,b-carotene-9,10-dioxygenase Q03393 2.9
*Solute carrier family 3, member 2 P40884 2.2
*Indolethylamine N-methyltransferase O95050 3.1
Aminopeptidase A Q07075 2.2
UDP-glucose ceramide glucosyl-
transferase
Q16739 2.3
Alpha-2,3-sialyltransferase Q02734 0.5
*Mannosidase alpha class 1A, member 1 P33908 0.3
Glycogen debranching enzyme P35573 0.4
PFKFB4 Q16877 0.5
Sorbitol dehydrogenase Q00796 0.4
Viral receptors
*Decay accelerating factor for complement P08174 2.7
Integrin 	2 P17301 3.1
Integrin 
1 P05556 2.8
Calcium homeostasis
*S100 calcium-binding protein A8 P05109 4.6
S100 calcium-binding protein A3
(S100A3/S110E)
P33764 3.1
Reticulocalbin 1, EF-hand calcium
binding domain
Q15293 2.5
Ca2 channel voltage-dependent, L type
subunit 	1D
Q01668 2.1
*Annexin A9 Q07936 0.4
*Stanniocalcin 1 P52823 0.4
Histones
H1 histone family member 2 P16403 2.2
*H2A histone family member N P02262 2.1
Miscellaneous
WD repeat domain 1 O88342 2.6
*Transmembrane 4 superfamily
member 1
P30408 3.5
*Nucleolar phosphoprotein Nopp34 Q9BYG3 2.6
Sperm-associated antigen 9 P34609 2.5
Albumin P02768 3.8
Prion protein (p27-30) P04156 2.4
Reticulon 2 (RTN2/NSP2/NSPL1) O75298 2.4
*Cysteine- and hystidine-rich domain
(CHORDC1)
Q9NZ93 2.8
Semaphorin L O75326 2.4
*Dedicator of cytokinesis 3 (IMAGE:
39922)
2.3
*Schwannomin-interacting protein 1
(IMAGE: 506143)
3.6
Uncharacterized bone marrow protein
BM040
Q9NZ82 2.2
*Enhancer of polycomb 1 Q9H7T7 2.6
Human proteinase activated receptor-2
mRNA, 3 UTR
P39195 2.2
*Arginine-rich, mutated in early-stage
tumors
Q9N3B0 3.1
*Epithelial stromal interaction 1
(IMAGE: 1855351)
2.3
*PVT1 (murine) oncogene homolog
(IMAGE: 295410)
2.8
*GE36 gene Q9H2B6 2.5
*Desmoplakin P15924 3
*Laminin, gamma 2 Q13753 3.6
Continued on following page
*Cylindromatosis (turnban tumor
syndrome)
Q9NQC7 3.1
*Serine (or cysteine) proteinase inhibitor P05120 5.7
*Brain-specific protein Q9Y326 4.6
Cornichon-like O95406 2.1
Karyopherin alpha 2 P52292 2.2
Phorbolin like protein MDS019 Q9UH17 3.1
Hematological and neurological
expressed 1
Q9UK76 2.3
Reelin P78509 3.5
*Golgin 67 Q9NZW0 0.5
Synaptogyrin 1 (SYNGR1) O43759 0.5
*Semaphorin 4G Q9WUH7 0.2
*Disabled (Drosophila) homolog 1 O75553 0.4
*H. sapiens LUCA-15 protein mRNA P52756 0.3
*G protein-coupled receptor GPRC5B Q9NZH0 0.3
*Upregulated by 1,25-dihydroxyvitamin D3 Q9H3M7 0.3
Wilm’s tumor 1-associating protein Q15007 0.4
HP1-BP74 Q9UHY0 0.4
TACC2 O95359 0.4
Mitochondrial ribosomal protein S14 O60783 0.4
Sorting nexin 17 Q15036 0.5
Lipin 2 Q92539 0.5
Amyotrophic lateral sclerosis 2 Q9C0K7 0.4
*Pleckstrin homology domain inter-
acting protein
Q9H261 0.3
Human reported sequencesd
*IMAGE: 1619049 COBW-like protein 2.6
*IMAGE: 70578 hypothetical protein
FLJI1362
3.1
*IMAGE: 858375 cDNA
DKFZp566J1846
2.6
*IMAGE: 788213 2.5
*IMAGE: 32241 KIAA0410 gene product 2.6
*IMAGE: 1659910 2.5
*IMAGE: 824031 2.4
*IMAGE: 841207 euroimage 2005735 2.9
*IMAGE: 814117 2.5
*IMAGE: 753907 cDNA
DKFZp434G227
3.5
*IMAGE: 1569107 hypothetical protein
FLJ20624
3
*IMAGE: 1947865 ORF 2.5
*IMAGE: 731270 hypothetical protein
FLJ20093
2.6
*IMAGE: 782195 DNA from clone
RP13-329D4
2.2
*IMAGE: 1619219 2.7
*IMAGE: 843250 EST 2.2
*IMAGE: 700625 CGI-09 protein 2.6
*IMAGE: 531343 KIAA0005 gene product 2.9
*IMAGE: 711993 KIAA1382 2.2
*IMAGE: 743190 2.4
*IMAGE: 1553025 hypothetical protein
FLJ20291
3.3
*IMAGE: 470232 3
*IMAGE: 502396 chromosome 21 ORF50 4.3
*IMAGE: 1657336 FLJ13672 fis clone
PLACE1011749
2.9
*IMAGE: 130747 FLJ13522 fis clone
PLACE1005884
2.9
*IMAGE: 61626 Putative 28-kDa protein 3.0
*IMAGE: 796508 KIAA0690 protein 3.5
*IMAGE: 447520 FLJ14241 fis clone
OVARC1000533
11.
*IMAGE: 461365 3.7
*IMAGE: 666138 DKFZp761J1523 protein 4.1
*IMAGE: 1929737 2.5
*IMAGE: 1689557 euroimage 1034327 2.9
*IMAGE: 290399 DKFZp5661133 protein 2.6
*IMAGE: 712604 2.2
*IMAGE: 289496 EST 4.8
*IMAGE: 235909 FLJ22554 fis clone
HSI01092
2.5
*IMAGE: 1536727 hypothetical protein
MGC11324
2.2
*IMAGE: 1628121 3.4
*IMAGE: 23933 clone 23933 mRNA
sequence
2.5
*IMAGE: 773324 hypothetical protein
FLJ10439
2.4
*IMAGE: 1031402 hypothetical protein 2.7
*IMAGE: 1625869 hypothetical protein
F23149_1
2.2
IMAGE: 54601 2.3
*IMAGE: 809533 hypothetical protein
MGC14376
3.8
*IMAGE: 489729 FLJ10768 fis clone
NT2RP4000150
5.3
*IMAGE: 79632 hypothetical protein
MGC13007
2.3
*IMAGE: 263342 hypothetical protein 2.4
*IMAGE: 1638584 3.4
*IMAGE: 283723 hypothetical protein
FLJ11021
2.9
*IMAGE: 950894 DKFZp761C169 pro-
tein
2.3
*IMAGE: 531036 hypothetical protein
MGC2975
4.3
*IMAGE: 130243 hypothetical protein
FLJ11036
4.7
*IMAGE: 45912 euroimage 45912 2.5
*IMAGE: 415976 FLJ13903 fis clone
THYRO1001854
3.1
IMAGE: 1565576 3
IMAGE: 788507 2.3
IMAGE: 809733 2.3
IMAGE: 826130 KIAA1527 protein 2
IMAGE: 328889 2.3
IMAGE: 1619109 2.4
IMAGE: 1740325 2.1
IMAGE: 825271 KIAA0029 protein 2.1
IMAGE: 767163 hypothetical protein
FLJ20425
2.7
IMAGE: 80463 2.3
IMAGE: 1606603 2.1
IMAGE: 1891596 2.6
IMAGE: 1032444 clone IMAGE: 3354845 2.2
IMAGE: 111437 2.6
IMAGE: 305843 CGI-47 protein 2.1
IMAGE: 784168 DKFZp564A072 2.3
IMAGE: 77361 CGI-97 protein 2.6
IMAGE: 302997 hypothetical protein
FLJ20036
2.6
IMAGE: 261472 putative nuclear
protein ORF1FL49
3.1
IMAGE: 449329 2.2
IMAGE: 814988 FLJ23130 fis clone
LNG08419
2.4
IMAGE: 49879 DKFZp761H229 2.4
IMAGE: 1696061 2.6
IMAGE: 713031 clone, IMAGE:
3457003
2.4
IMAGE: 489106 hypothetical protein
FLJ11210
2.5
IMAGE: 1836586 2.6
IMAGE: 563860 2.4
IMAGE: 75044 2.6
IMAGE: 757265 hypothetical protein
MGC4399
2.7
IMAGE: 812069 DKFZp586F1323 2.2
IMAGE: 884346 hypothetical protein
FLJ20323
2.4
IMAGE: 666110 KIAA0580 protein 2.1
IMAGE: 357117 hypothetical protein
FLJ13194
2.2
IMAGE: 1713773 2.2
IMAGE: 251769 2.1
IMAGE: 52128 2.1
IMAGE: 491465 DKFZp4340531 protein 2.3
IMAGE: 1524481 2.2
IMAGE: 454970 DKFZp434G032 protein 3.2
IMAGE: 529302 FLJ11765 fis clone
HEMBA 1005891
2.1
IMAGE: 588492 3
IMAGE: 713205 CGI-94 protein 2.4
IMAGE: 502201 2.2
IMAGE: 1856516 2.1
IMAGE: 1950727 2.2
IMAGE: 629498 2.2
IMAGE: 1696757 hypothetical protein
KIAA1165
2.3
IMAGE: 502739 hypothetical protein
FLJ11010
2.1
IMAGE: 265626 2.3
IMAGE: 358333 FLJ20153 fis clone
COL08656
2.3
IMAGE: 429446 2.5
IMAGE: 428529 2.4
IMAGE: 1536628 2.4
IMAGE: 771165 hypothetical protein
FLJ14697
2.2
IMAGE: 1570339 clone, IMAGE: 3948909 2.3
IMAGE: 452863 hypothetical protein
AD034
2.2
IMAGE: 449403 2.7
IMAGE: 45801 2.4
IMAGE: 428824 hypothetical protein
FLJ13605
2.7
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ment did not include the extensive number of controls and
duplicates used in our primary experiment, the results clearly
show that very few of the transcriptional changes observed at
16 hpi are detected at 6 hpi (Fig. 5 and Table 2). Hence, it
seems likely that the majority of host transcriptional changes
observed are not due to the early host cell binding and entry
events, although direct experiments need to be carried out to
confirm this hypothesis.
At 16 hpi we detected 508 genes (represented by 576 array
elements), out of 8,575 analyzable genes, that were up- or
downregulated. This number represents 6.7% of the analyz-
able genes. Several studies of the transcriptional response to
other viral infections have recently been reported (7, 20, 21, 42,
60), and a brief discussion of these studies is provided. Based
on the reported numbers of regulated and total analyzed genes
in previous reports, the percentage of modulated transcripts
after virus infection varies between 1.3 and 7% (7, 20, 21, 60).
Infection of primary human foreskin fibroblasts with human
cytomegalovirus (60), and the CD4 T-cell line CEM-CCRF
with HIV-1-LAI (21) produced a balanced mix between up-
and downregulated genes. Similar findings were observed when
human keratinocytes were transfected with HPV31 cDNA (7).
In contrast, influenza virus infection of HeLa cells (20) induced
a transcriptional response characterized primarily by down-
regulation. In all cases, as in RRV infection, the magnitude of
the response increased over time. This is not surprising since,
with increasing time, more stages of the virus replication cycle
occur and more viral proteins are expressed. These ongoing
steps in viral replication can activate additional signal trans-
duction pathways that can generate new responses in the cell.
In addition, the increase of the transcriptional responses over
time could be due to paracrine effects in which newly synthe-
sized proteins from infected cells interact with neighboring un-
infected cells, resulting in additional transcriptional changes.
Comparison with previous reports of rotavirus-induced re-
sponses. Rotavirus infection induces profound alterations in
the morphology and biochemistry of the host cell; however, the
molecular mechanisms underlying these events are not fully
understood. Previous work in MA104 cells demonstrated an
upregulation, at the mRNA and protein level, of BiP (grp78)
TABLE 3—Continued
Function and
gene namea
SwissProt
accession
no.b
FCc
Function and
gene namea
SwissProt
accession
no.b
FCc Function andgene namea
SwissProt
accession
no.b
FCc
IMAGE: 840467 hypothetical protein
FLJ11259
2.5
IMAGE: 488155 hypothetical protein
FLJ12787
2.7
*IMAGE: 45601 EST 2.3
IMAGE: 1916461 hypothetical protein 2.6
IMAGE: 811572 2.4
IMAGE: 773331 clone RP11-353C18 2.4
*IMAGE: 815069 cDNA
DKFZp564D0472
0.4
*IMAGE: 1570502 FLJ12936 fis
NT2RP200518
0.4
*IMAGE: 40120 KIAA0941 protein 0.4
*IMAGE: 131099 FLJ13057 protein 0.3
*IMAGE: 841146 DKFZp566G1424
protein
0.3
*IMAGE: 1836834 KIAA1055 protein 0.4
*IMAGE: 285312 0.4
*IMAGE: 32805 0.3
*IMAGE: 240896 hypothetical protein 0.4
*IMAGE: 342399 cDNA
DKFZp434A2410
0.4
*IMAGE: 824312 FLJ10229 fis
HEMBB1000136
0.4
*IMAGE: 69378 FLJ23165 fis clone
LNG09846
0.5
*IMAGE: 951068 cDNA
DKFZp566E183
0.4
*IMAGE: 32495 FLJ22150 fis clone
HRC00109
0.5
*IMAGE: 427797 0.4
*IMAGE: 429433 MGC11242 protein 0.3
*IMAGE: 767721 FLJ13604 fis
PLACE1010401
0.3
*IMAGE: 1926272 EST 0.4
*IMAGE: 212542 FLJ12900 fis
NT2RP2004321
0.5
*IMAGE: 132015 hypothetical protein
FLJ23516
0.4
*IMAGE: 429811 Homo sapiens clone
122482
0.3
*IMAGE: 1055460 0.4
*IMAGE: 42935 EST 0.4
a As registered in SMD (52). Some genes are grouped according to related biological function. *, Genes whose transcriptional level changed more than twofold in
all three experimental hybridizations (see Table 1).
b Not indicated for human reported sequences. For genes that do not have a SwissProt accession number, the IMAGE number is indicated. The SwissProt entry is
copyright. It is produced through a collaboration between the Swiss Institute of Bioinformatics and the EMBL outstation of the European Bioinformatics Institute.
There are no restrictions on its use by nonprofit institutions as long as its content is in no way modified, and this statement is not removed. Usage by and for commercial
entities requires a license agreement (see http://www.isb-sib.ch/announce/).
c FC, fold change. Values of 2 and 0.5 correspond to up- and downregulated genes, respectively.
d As reported in the IMAGE human cDNA collection (36) (also traceable at http://genome-www5.stanford.edu/cgi-bin/SMD/source/sourceSearch/).
*IMAGE: 588368 KIAA0947 protein 0.4
*IMAGE: 461118 EST 0.4
*IMAGE: 1909433 DKFZp727C091
protein
0.4
*IMAGE: 826622 KIAA0430 gene
product
0.4
*IMAGE: 1909873 FLJ20051 protein 0.4
*IMAGE: 80292 FLB3344 PRO0845 0.4
*IMAGE: 22908 EST 0.3
*IMAGE: 840974 hypothetical protein
FLJ10743
0.5
*IMAGE: 1552117 EST 0.4
*IMAGE: 126851 hypothetical protein
FLJ11160
0.5
*IMAGE: 291426 KIAA1846 protein 0.4
*IMAGE: 256947 EST 0.3
*IMAGE: 32206 KIAA0774 protein 0.3
*IMAGE: 767172 euroimage 248114 0.4
*IMAGE: 238907 protein,
Strait02270_FL142
0.4
*IMAGE: 135106 DKFZp434C0328 0.4
*IMAGE: 1461528 EST 0.3
IMAGE: 26414 0.4
*IMAGE: 814616 EST 0.4
*IMAGE: 428782 hypothetical protein
PRO2730
0.3
*IMAGE: 1908712 hypothetical
protein
0.4
*IMAGE: 196435 EST 0.4
*IMAGE: 46896 hypothetical protein
PRO1331
0.3
IMAGE: 784258 hypothetical protein
my014
0.5
IMAGE: 773185 0.4
IMAGE: 51879 0.4
IMAGE: 451646 KIAA0924 0.4
IMAGE: 1656557 0.4
IMAGE: 503671 FLJ14368 fis HEMBA
1001122
0.3
IMAGE: 1049346 hypothetical protein 0.4
IMAGE: 511091 0.4
IMAGE: 194399 cDNA
DKFZp586B1722
0.22
IMAGE: 950945 cDNA
DKFZp564P0823
0.4
IMAGE: 725143 hypothetical protein
FLJ22418
0.4
IMAGE: 502794 FLJ21435 fis clone
COL04244
0.4
IMAGE: 111006 0.4
IMAGE: 742569 hypothetical protein
FLJ00026
0.4
IMAGE: 412989 FLJ13634 fis
PLACE1011133
0.4
IMAGE: 29965 FLJ22071 fis clone
HEP11691
0.4
IMAGE: 298937 hypothetical protein
dJ551D2.5
0.4
IMAGE: 624379 KIAA0740 gene prod-
uct
0.4
IMAGE: 296616 hypothetical protein
FLJ21174
0.5
IMAGE: 259953 KIAA1600 protein 0.4
IMAGE: 47080 hypothetical protein
MGC13033
0.5
IMAGE: 1853547 KIAA1572 protein 0.5
IMAGE: 811025 hypothetical protein 0.4
IMAGE: 303139 hypothetical protein
FLJ14054
0.4
IMAGE: 742596 0.4
IMAGE: 665127 clone 747H23 chrom
6q13-15
0.5
IMAGE: 435208 0.5
IMAGE: 1160531 0.5
IMAGE: 1883621 0.4
IMAGE: 1622129 0.4
IMAGE: 45921 human clone 23908
mRNA
0.5
IMAGE: 247216 DKFZp586F1322 0.5
IMAGE: 1900362 0.4
IMAGE: 71730 FLJ21278 fis clone
COL01832
0.4
IMAGE: 725473 DNA segment on
chromosome
0.5
IMAGE: 646753 0.4
IMAGE: 1627504 0.4
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and endoplasmin (grp94, tumor rejection antigen 1), two pro-
teins resident of the ER, and members of a family of glucose-
regulated chaperones (58). In accordance with that report, we
also found upregulation of the gene that encodes endoplasmin
(grp94, tumor rejection antigen 1); unfortunately, we could not
evaluate the transcriptional response of Bip (grp78) because
this gene was excluded from our analysis due to its variability
in the control comparisons (mock versus mock). Supporting
the hypothesis that cellular chaperones might be involved in
the process of rotavirus maturation in the ER, we did find
upregulation of members of the major classes of general chap-
erons such as HSP40, HSP70, and HSP90 that assist the folding
process in the ER (see Table 3, stress response category).
Increases in cytokine gene expression in response to rotavi-
rus infection had previously been reported by Rollo et al. (46).
The transcriptional activity of genes encoding a variety of
chemokines in HT-29 cells was analyzed by RT-PCR. These
authors reported the induction of C-X-C chemokines, includ-
ing interleukin-8 (IL-8), IP-10, and GRO, and the induction
of C-C chemokines such as RANTES and monocyte chemo-
attractant protein 1 (MCP1). In addition, genes encoding
IFN-	 and granulocyte-macrophage colony-stimulating factor
(GM-CSF) were found to be upregulated in this analysis. Con-
versely, the transcripts for tumor necrosis factor alpha (TNF-
	), IL-1	, IL-1
, and IFN-
 were not increased after rotavirus
infection of HT-29 cells. In agreement with these previous
reports, the level of mRNA encoding RANTES was upregu-
lated 2.6-fold in our analysis. The gene that encodes GRO
was not present on the microarrays in this study. We also found
a slight upregulation of GM-CSF and GRO	, but these genes
were not included in our final listing because they did not reach
the twofold threshold value. The transcriptional response of
IL-6, MCP1, and TNF-	 genes was not evaluated due to their
variability in the control comparisons, and the genes encoding
for IP10, IL-1	, and IL-1
 were not analyzed because they
were not present on the microarrays.
Examination and analysis of the list of 508 regulated genes
identified several families of genes with different functions
(Table 3). Some of these groups include genes encoding inte-
gral membrane proteins, IFN-related genes, transcriptional
and translational regulators, and others. Some of these may be
involved in processes such as viral replication or cell defense. A
clear understanding of the mechanistic relationship between
transcriptional regulation changes and rotavirus replication
will require additional studies. However, it is reasonable to
begin to examine some of the data obtained here and to spec-
ulate on possible relationships between the host transcriptional
response observed and the viral replication cycle.
Viral cellular receptors are upregulated in RRV-infected
Caco-2 cells. Among the transcripts upregulated in infected
Caco-2 cells, integrin 	2 and integrin 
1 were identified. Inter-
estingly, it has been shown that integrin 	2
1 can mediate
attachment and entry of rotavirus into cells (26). Other inte-
grins that were also implicated in rotavirus entry did not pass
the filter criteria in this analysis (integrin 	4) (26), were not
included in the array (integrin 	5) (24), or were not upregu-
lated on the basis of our criteria (integrin 
3) (24). The tran-
script of a homolog of HSP70, HSPA1L, was also upregulated
in rotavirus-infected cells. Members of this family of heat
shock proteins have been proposed to mediate rotavirus entry
in MA104 cells (23). The mRNA transcript for sialic acid
synthase, an enzyme involved in the biosynthetic pathway of
sialic acids, was also upregulated. Some animal strains of ro-
tavirus, including RRV, attach to sialic acid moieties on the
cell surface prior to cell entry (18, 31). Although the protein
expression of these putative viral receptor transcripts needs to
be directly measured, upregulation of these receptor mRNAs
raises several interesting possibilities. Rotavirus infection
might upregulate expression of its own cellular receptor to
facilitate viral entry. In this way the infected cell would be
more likely to be suprainfected with new infectious particles,
although the importance of suprainfection of cells “in vivo” is
not known. Another possibility is that rotavirus infection might
enhance receptor upregulation in surrounding uninfected cells,
thereby facilitating the spread of the infection. Since 75% of
the cells were infected in our experiments (Fig. 1) and mRNA
from all of the cells in the infected flasks was examined, we
cannot determine from this analysis if integrin, HSPA1L, or
sialic acid synthase regulation took place in the noninfected
surrounding cells. It will be interesting to carry out additional
studies at lower MOIs, sort infected and noninfected cells, and
then look at the cellular response in the two separate popula-
tions. It is also possible that the cell upregulated the expression
of putative rotavirus receptors as a defense mechanism to
block viral release and spread. Overexpression of the rotavirus
receptors in infected cells could mediate binding and “neutral-
ization” of the newly formed and shed viral particles. It has
been shown that high levels of cell surface expression of CD4,
the cellular receptor for HIV-1, reduces the infectivity of the
released virions by sequestering the viral envelope (34).
Translation regulation in RRV-infected Caco-2 cells. Sev-
eral genes involved in protein synthesis were upregulated after
rotavirus infection. These include six eukaryotic translation
initiation factors (eIF1A, eIF2S2, eIF2B2, eIF3S1, eIF3S5, and
eIF4A1), four tRNA synthetases (alanyl, phenylalanyl, lysyl,
and tyrosyl tRNA synthases), and four DEAD box proteins
(DEAD/H box polypeptides 3, 16, and 21 and Y chromosome)
(putative RNA helicases, involved in translation initiation). No
translation elongation factors were found to be modulated
in this analysis. It has been shown that rotavirus infection
mediates a reduction of cellular protein synthesis, favoring
translation of viral proteins (25, 45). If the upregulation of the
translation associated genes seen here is correlated with an
upregulation of the corresponding host proteins, one might
speculate that rotavirus induces an upregulation of the protein
translation machinery of the cell and uses this machinery for
the synthesis of its own proteins, while simultaneously blocking
host cellular protein synthesis. In this manner, two mechanisms
could be used by the virus for efficient translation of its own
proteins. One would involve an upregulation of cellular trans-
lation factors for a more efficient translation of viral proteins,
and the other would direct the cell translation machinery to
specifically favor viral genes due to the specific interaction of
NSP-3 and eIF4G1 (45).
IFN response to RRV infection. Among the 508 genes dif-
ferentially regulated after 16 h of rotavirus infection, six are
IFN-inducible genes: 25-oligoadenylate synthetase 1 (OAS1),
IFN regulatory factor 2 (IRF2), IFN-related developmental
regulator 1 (IFRD1), IFN-induced protein with tetratricopep-
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tide repeats 1 (IFIT1), guanylate binding protein 1 (GBP1),
and IFN--inducible protein 16 (IFI16).
IFNs are a large family of secreted proteins that were ini-
tially discovered because of their antiviral activity. It is clear
now that, in addition to this function, IFNs also modulate cell
growth, immune response, and antitumor activities (reviewed
in references 50 and 53). The IFN-induced gene products that
play a major role in fighting viral infections include OAS1,
RNase L, the Mx proteins, and the PKR protein kinase (47).
Among the IFN-regulated genes that were differentially ex-
pressed in this study, we found several genes whose products
have been previously shown to establish an antiviral state dur-
ing viral infections, including IRF2, OAS1, and GBP1. The
upregulation of the gene encoding OAS1 is potentially signif-
icant. This synthetase is stimulated by dsRNA to produce 2-
5-linked oligoadenylates. The principal function of these
products is to activate the latent RNase L, which in turn de-
grades viral and cellular single-stranded RNA (ssRNA). Dur-
ing its replication, rotavirus generates viral dsRNA as well as
ssRNA with a double-stranded secondary structure. If the in-
crease in mRNA of OAS1 detected in this analysis reflects an
increase of this protein, we can suggest that the OAS1/RNase
L system is a mechanism of cellular defense against rotavirus
infection. The activation of PKR, another protein with an
alternative antiviral effect by rotavirus dsRNA, has also been
proposed (46).
Several previous reports suggested a possible role for IFNs
in host defense against rotavirus infectious. In vitro, IFN-	,
and IFN- pretreatment inhibits rotavirus entry into human
intestinal cell lines (3). Rollo et al. found activation of the
IFN-induced transcription factor ISGF3 in HT-29 cells, indi-
cating that RRV infection induces a sustained production and
action of IFN-	/
 that begins a few hours after infection (46).
In vivo, administration of IFN-	/
 to pigs and calves dimin-
ished virus replication and diarrhea (35, 49), and high levels of
IFN-	/
 and the antiviral IFN-induced protein MxA were
found in the peripheral blood cells of patients and animals
infected with rotavirus (8–10, 33, 38). From these and our own
findings it seems likely that rotavirus-infected cells efficiently
activate the transcription of many IFN-induced genes to create
an antiviral state. In contrast, studies to directly determine the
importance of IFNs in modulating rotavirus disease and infec-
tion in vivo have shown that the lack of IFN did not augment
the intensity of diarrhea or change the amount of virus shed-
ding (1). Moreover, a previous report from our laboratory
demonstrated that IFN- is not an essential mediator of the
antirotavirus effect of CD8 T cells since IFN- knockout mice
and mice depleted of IFN by administration of an anti-IFN-
monoclonal antibody cleared rotavirus infection as efficiently
as control mice (17).
The apparent discrepancy between the transcriptional acti-
vation of IFN-induced genes and the lack of a role of endog-
enous IFNs in the resolution of rotavirus disease and infection
in the mouse model could be explained by the existence of a
specific viral mechanism designed to blunt or eliminate the
IFN response of the host cell. Different mechanisms of resis-
tance to IFN effects have been reported in different viral sys-
tems. For example, Kaposi sarcoma-associated herpesvirus en-
codes a gene product that has homology to the IRF family of
transcription factors and inhibits the response to IFN-	/
 and
IFN- (61). The dsRNA-binding protein NS1 of influenza A
virus inhibits the activation of IRF3, presumably by sequester-
ing double-stranded forms of RNA which could potentially
activate IRF-3 and initiate the induction of an antiviral state
(56). Others viruses, including adenovirus and Epstein-Barr
virus, inhibit the IFN-induced PKR by a virus-encoded RNA
that binds to PKR and impairs its activation by dsRNA (re-
viewed in reference 19). The activity of the OAS1/RNase L
system is also target of inhibition by several viruses, such as
EMCV and herpes simplex virus (51). Recently, was shown
that the influenza B virus protein NS1 blocks the function of
the IFN-inducible protein ISG15 (59). Since viruses have de-
veloped a variety of countermechanisms to block the antiviral
response of IFNs, we speculate that rotavirus may also have
developed an IFN-interfering mechanism to overcome host
cell defense. The identification and characterization of such
mechanisms warrants further investigation.
Rotavirus infection and calcium homeostasis. Several stud-
ies indicate that calcium is a critical factor in rotavirus cytopa-
thology. On the one hand, this cation is required for rotavirus
morphogenesis, while on the other hand calcium accumulation
appears to be responsible for the cytopathic effect and cell
death observed at late stages of infection. The alteration of
calcium homeostasis during rotavirus infection has been di-
rectly related to the synthesis of specific viral proteins. Recent
studies have found that the rotavirus nonstructural protein NSP4
increases the intracellular calcium concentration ([Ca2]i) when
expressed endogenously in Sf9 insect cells or when added ex-
ogenously to Sf9 or human intestinal HT-29 cells (13, 57). NSP4
has been shown to be an enterotoxin that induces diarrhea in
young mice; the physiological evidence suggests that NSP4
activates a signal transduction pathway that increases [Ca2]i
by mobilizing Ca2 from the ER and resulting in transepithe-
lial chloride secretion (2).
In addition to the role of NSP4 in the changes in [Ca2]i, del
Castillo et al. and Perez et al. have found a progressive in-
crease in plasma membrane permeability to mono and divalent
cations a few hours after rotavirus infection (11, 44). The
characterization of the Ca2 entry pathway suggests that rota-
virus infection activates an L-type Ca2channel of the plasma
membrane in MA104 and HT-29 cells (44). Interestingly, in
this study we reported the upregulation of the alpha 1D sub-
unit of this L-type calcium channel, supporting the involvement
of this channel in the pathway of plasma membrane perme-
ability observed during rotavirus infection.
The genes encoding for S100A3 and S100A8 were also up-
regulated. These proteins belong to a family of low-molecular-
weight Ca2-binding proteins of the EF-hand type known as
S100. Previous work has implicated S100 proteins in Ca2-
dependent regulation of intracellular and extracellular func-
tions such as protein phosphorylation, calcium homeostasis,
inflammation, and regulation of the dynamics of cytoskeleton
components (12).
The three major constituents of the cytoskeleton—microtu-
bules, microfilaments, and intermediate filaments—are targets
of S100 proteins (reviewed in reference 12). It is now well
documented that members of this protein family inhibit tubulin
polymerization and cause disassembly of preformed microtu-
bules in the presence of micromolar concentrations of free
[Ca2]i. The S100A8/S100A9 complex modulates Ca
2-de-
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pendent interactions between vimentin, keratin intermedi-
ate filaments, and membranes. S100A2 plays a role in the
organization of the actin cytoskeleton by regulating F actin-
tropomyosin interactions in epithelial cell lines in a Ca2-
dependent manner. It is interesting that the rotavirus-induced
increases in [Ca2]i have been shown to be directly responsible
for the disassembly of microvillar F-actin and the microtubule
network in differentiated Caco-2 cells at late times after rota-
virus infection (5, 6). If the increase in mRNA of S100A3 and
S100A8 reported in this analysis reflects an increase of these
proteins, it seems possible that these proteins participate in the
Ca2-dependent disorganization of cytoskeleton observed in
RRV-infected cells.
In summary, we have studied the relative abundance of more
than 8,000 human transcripts in Caco-2 cells infected with
rotavirus. We learned that 6.7% of the analyzable transcripts
were regulated at 16 hpi, 73.4% of them being upregulated
genes, and the majority of the changes observed occurred late
after infection, primarily at or after 12 h. This global analysis
provides a new picture of the cellular response to rotavirus
infection. Although the relationships between cellular mRNA
levels and the rotavirus replication cycle are not clear, further
characterization of the response of individual genes can pro-
vide a better understanding of host-pathogen interaction. Fu-
ture studies should also focus on which components of the
virus replication cycle (binding, entry, transcription and trans-
lation, assembly, etc.) are responsible for the transcriptional
changes observed, which viral genes mediate these changes and
whether the transcriptional response program identified in this
cell culture model is representative of changes seen in the
intestine in vivo.
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